CLINICAL_TRIALS
trial_result
· 2018-10-16
Clinical Trial Update: Randomized Double-blind Controlled Trial of Use of Dydrogesterone in Threatened Miscarriage [Phase 3]
Summary
Phase 3 randomized, double-blind trial evaluating dydrogesterone for threatened miscarriage has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The University of Hong Kong | Conditions: Pregnancy | Phase 3 | Status: COMPLETED